Gilead announces research fellows and partners for Community Champions program

December 1, 2023 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Gilead Sciences Australia has marked World AIDS Day by announcing the first cohort’s completion of an HIV fellowship program and partnered with NAPWHA to celebrate the unsung heroes of the Australian HIV response. …

Subscribe now to continue reading.

Latest Video

Pfizer clinches Metsera, reshaping the balance in global obesity therapy race
November 11, 2025 - Latest News
CSL welcomes MSAC support for gene therapy but questions 'strict cost-neutrality framework'
November 11, 2025 - Latest News
New Zealand accelerates medicines reform with major regulatory changes
November 12, 2025 - Latest News
Professor Robyn Ward - 'AI won’t replace us, but it will redefine how we work'
November 11, 2025 - Latest News
'AI Must Be trusted, transparent, and integrated in the future of health technology assessment'
November 11, 2025 - Latest News

Gilead announces research fellows and partners for Community Champions program

This is a preview of subscriber content

Latest Video

Most Read

Pfizer clinches Metsera, reshaping the balance in global obesity therapy race

CSL welcomes MSAC support for gene therapy but questions 'strict cost-neutrality framework'

New Zealand accelerates medicines reform with major regulatory changes

Professor Robyn Ward - 'AI won’t replace us, but it will redefine how we work'

'AI Must Be trusted, transparent, and integrated in the future of health technology assessment'

New Stories

Sanofi building an AI-literate organisation through expectations, over experiments

The four 'H' words that can help drive the adoption of AI in health

Immutep posts encouraging Phase 2 results as 'Efti' spurs robust anti-tumour activity

PYC Therapeutics appoints Peter Coleman as new Chair as part of board renewal

New gene discoveries improve diagnosis of inherited heart disease

Chimeric Therapeutics reports strong early results from CHM CDH17 Phase 1/2 trial

Australia joins global WHO task force to tackle antimicrobial resistance

Sign In

Gilead announces research fellows and partners for Community Champions program

This is a preview of subscriber content

Latest Video

Most Read

Pfizer clinches Metsera, reshaping the balance in global obesity therapy race

CSL welcomes MSAC support for gene therapy but questions 'strict cost-neutrality framework'

New Zealand accelerates medicines reform with major regulatory changes

Professor Robyn Ward - 'AI won’t replace us, but it will redefine how we work'

'AI Must Be trusted, transparent, and integrated in the future of health technology assessment'

Follow Us

New Stories

Sanofi building an AI-literate organisation through expectations, over experiments

The four 'H' words that can help drive the adoption of AI in health

Immutep posts encouraging Phase 2 results as 'Efti' spurs robust anti-tumour activity

PYC Therapeutics appoints Peter Coleman as new Chair as part of board renewal

New gene discoveries improve diagnosis of inherited heart disease

Chimeric Therapeutics reports strong early results from CHM CDH17 Phase 1/2 trial

Australia joins global WHO task force to tackle antimicrobial resistance